LILLY MEDICINE FOUNDRY
Live / Applied — First extension granted (statement of use) (as of 06 Oct 2025)
What this means for you
Not registered yet, but its 01 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98780389
- Mark type
- Stylized text
- Filed
- 01 Oct 2024
- Published for opposition
- 11 Mar 2025
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 040 — Treatment of materials: Custom manufacturing of pharmaceuticals and clinical trial materials
- Class 042 — Scientific and technological services: Pharmaceutical products development; Product research; Research and development in the pharmaceutical and biotechnology fields
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 06 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Oct 2025 — SOU EXTENSION 1 GRANTED
- 06 Oct 2025 — SOU EXTENSION 1 FILED
- 06 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 06 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION
- 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Feb 2025 — EXAMINER'S AMENDMENT ENTERED
- 13 Feb 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Feb 2025 — EXAMINERS AMENDMENT E-MAILED
- 13 Feb 2025 — EXAMINERS AMENDMENT -WRITTEN
- 05 Feb 2025 — ASSIGNED TO EXAMINER
- 01 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED